#treatmentoptions — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #treatmentoptions, aggregated by home.social.
-
European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union
SAN DIEGO, August 24, 2026–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European …
#Europe #EU #ACADIAPharmaceuticals #DAYBU #EuropeanCommission #EuropeanUnion #neurodevelopmentaldisorder #pediatricpatients #raredisease #Rettsyndrome #treatmentoption #treatmentoptions
https://www.europesays.com/europe/122619/ -
Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease
Sanofi Winthrop Industrie Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease Paris, March 31, 20…
#France #FR #Europe #EU #Sanofi #chronicGVHD #clinicalstudies #EuropeanMedicinesAgency #graft-versus-hostdisease #marketingauthorisation #ROCKstar #SorbonneUniversity #stemcelltransplant #systemictherapy #TheEuropeanCommission #treatmentoptions
https://www.europesays.com/france/19451/ -
Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease
Sanofi Winthrop Industrie Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease Paris, March 31, 2026.…
#Europe #EU #chronicGVHD #clinicalstudies #EuropeanMedicinesAgency #EuropeanUnion #graft-versus-hostdisease #marketingauthorisation #ROCKstar #Sanofi #SorbonneUniversity #stemcelltransplant #systemictherapy #TheEuropeanCommission #treatmentoptions
https://www.europesays.com/europe/2080/